

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64531024 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49374200 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49374200 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.24434423 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19964460 |
| 6 | protein localization to endosome (GO:0036010) | 4.09183385 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.92549511 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.92549511 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.92549511 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.92549511 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.92549511 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.92549511 |
| 13 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.74479092 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65519027 |
| 15 | mannose metabolic process (GO:0006013) | 3.64051534 |
| 16 | virion attachment to host cell (GO:0019062) | 3.58688196 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 3.58688196 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.49968406 |
| 19 | adhesion of symbiont to host (GO:0044406) | 3.35478488 |
| 20 | respiratory burst (GO:0045730) | 3.34676288 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.31271942 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28987218 |
| 23 | amino sugar catabolic process (GO:0046348) | 3.26986309 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.26779898 |
| 25 | fibril organization (GO:0097435) | 3.23507109 |
| 26 | extracellular fibril organization (GO:0043206) | 3.23070709 |
| 27 | response to peptidoglycan (GO:0032494) | 3.13895236 |
| 28 | stress fiber assembly (GO:0043149) | 3.07031379 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.05469016 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.05469016 |
| 31 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.04704022 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04105801 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.03891950 |
| 34 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01223396 |
| 35 | glycosphingolipid catabolic process (GO:0046479) | 2.99758277 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 2.99520139 |
| 37 | skin morphogenesis (GO:0043589) | 2.97777761 |
| 38 | pinocytosis (GO:0006907) | 2.91263407 |
| 39 | hyaluronan catabolic process (GO:0030214) | 2.90597777 |
| 40 | protein maturation by protein folding (GO:0022417) | 2.89308470 |
| 41 | UV protection (GO:0009650) | 2.85233463 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84496625 |
| 43 | response to interferon-beta (GO:0035456) | 2.84468581 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79218024 |
| 45 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78629676 |
| 46 | regulation of antigen processing and presentation (GO:0002577) | 2.75719870 |
| 47 | mitochondrial calcium ion transport (GO:0006851) | 2.75374893 |
| 48 | signal peptide processing (GO:0006465) | 2.73684244 |
| 49 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71042427 |
| 50 | aldehyde catabolic process (GO:0046185) | 2.69484659 |
| 51 | cellular response to type I interferon (GO:0071357) | 2.69107847 |
| 52 | type I interferon signaling pathway (GO:0060337) | 2.69107847 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.68535916 |
| 54 | glycolipid catabolic process (GO:0019377) | 2.68074138 |
| 55 | apoptotic cell clearance (GO:0043277) | 2.68000613 |
| 56 | response to type I interferon (GO:0034340) | 2.67972560 |
| 57 | cellular response to arsenic-containing substance (GO:0071243) | 2.67894927 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66587253 |
| 59 | membrane raft organization (GO:0031579) | 2.65187621 |
| 60 | regulation of cholesterol storage (GO:0010885) | 2.64416695 |
| 61 | type B pancreatic cell proliferation (GO:0044342) | 2.63572579 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 2.63371386 |
| 63 | response to interferon-alpha (GO:0035455) | 2.62286813 |
| 64 | amyloid precursor protein catabolic process (GO:0042987) | 2.62161837 |
| 65 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60979563 |
| 66 | positive regulation of receptor recycling (GO:0001921) | 2.60555650 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 2.57891845 |
| 68 | granulocyte activation (GO:0036230) | 2.57263459 |
| 69 | myeloid cell homeostasis (GO:0002262) | 2.56267370 |
| 70 | mature B cell differentiation involved in immune response (GO:0002313) | 2.55309585 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.52592219 |
| 72 | response to progesterone (GO:0032570) | 2.51782040 |
| 73 | reactive oxygen species biosynthetic process (GO:1903409) | 2.51375959 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51087543 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.50870058 |
| 76 | positive regulation of interferon-beta production (GO:0032728) | 2.50728890 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48427676 |
| 78 | glial cell migration (GO:0008347) | 2.47779251 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.47472253 |
| 80 | protein retention in ER lumen (GO:0006621) | 2.47332182 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.47030432 |
| 82 | detection of other organism (GO:0098543) | 2.46851187 |
| 83 | response to host immune response (GO:0052572) | 2.46335536 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.46335536 |
| 85 | detection of bacterium (GO:0016045) | 2.46316468 |
| 86 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.46168570 |
| 87 | positive regulation of extracellular matrix organization (GO:1903055) | 2.46090338 |
| 88 | neutrophil activation (GO:0042119) | 2.45747218 |
| 89 | natural killer cell mediated immunity (GO:0002228) | 2.45192439 |
| 90 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.45192439 |
| 91 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.44390551 |
| 92 | response to laminar fluid shear stress (GO:0034616) | 2.41682426 |
| 93 | response to thyroid hormone (GO:0097066) | 2.40961062 |
| 94 | regulation of necrotic cell death (GO:0010939) | 2.40607895 |
| 95 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.40210993 |
| 96 | cellular response to interferon-beta (GO:0035458) | 2.38905588 |
| 97 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37959450 |
| 98 | keratan sulfate catabolic process (GO:0042340) | 2.37907355 |
| 99 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.36013529 |
| 100 | protein carboxylation (GO:0018214) | 2.36013529 |
| 101 | GDP-mannose metabolic process (GO:0019673) | 2.35629344 |
| 102 | B cell mediated immunity (GO:0019724) | 2.34631244 |
| 103 | decidualization (GO:0046697) | 2.33848853 |
| 104 | regulation of superoxide anion generation (GO:0032928) | 2.33379229 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.33329492 |
| 106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.32790531 |
| 107 | pentose-phosphate shunt (GO:0006098) | 2.32506650 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.32433657 |
| 109 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.31571737 |
| 110 | basement membrane organization (GO:0071711) | 2.31248211 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 2.31053528 |
| 112 | oligosaccharide catabolic process (GO:0009313) | 2.30745552 |
| 113 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.30588701 |
| 114 | adenosine receptor signaling pathway (GO:0001973) | 2.29720021 |
| 115 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29497394 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.29051259 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.28914114 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28521243 |
| 119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.28426932 |
| 120 | hypotonic response (GO:0006971) | 2.27815466 |
| 121 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27760016 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.26154417 |
| 123 | glucose catabolic process (GO:0006007) | 2.26099407 |
| 124 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.25760750 |
| 125 | cortical actin cytoskeleton organization (GO:0030866) | 2.25666938 |
| 126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.25125044 |
| 127 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.25050809 |
| 128 | NADPH regeneration (GO:0006740) | 2.24880427 |
| 129 | ceramide catabolic process (GO:0046514) | 2.24513103 |
| 130 | negative regulation of cell size (GO:0045792) | 2.24292228 |
| 131 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.23895995 |
| 132 | macrophage activation (GO:0042116) | 2.23892643 |
| 133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.23776964 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.22760531 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.22422089 |
| 136 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.22100432 |
| 137 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.21567301 |
| 138 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.21255866 |
| 139 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.20892927 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.20853900 |
| 141 | peptide catabolic process (GO:0043171) | 2.20488804 |
| 142 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.20334542 |
| 143 | negative regulation of lipid storage (GO:0010888) | 2.19776895 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.19344808 |
| 145 | negative regulation of mast cell activation (GO:0033004) | 2.18777804 |
| 146 | primary alcohol catabolic process (GO:0034310) | 2.17989563 |
| 147 | barbed-end actin filament capping (GO:0051016) | 2.17462908 |
| 148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.17154938 |
| 149 | response to host (GO:0075136) | 2.17154938 |
| 150 | response to host defenses (GO:0052200) | 2.17154938 |
| 151 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.16175537 |
| 152 | regulation of podosome assembly (GO:0071801) | 2.15562771 |
| 153 | positive regulation of B cell differentiation (GO:0045579) | 2.13260150 |
| 154 | actin nucleation (GO:0045010) | 2.12925117 |
| 155 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.12869097 |
| 156 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.12632465 |
| 157 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.11810714 |
| 158 | cellular response to zinc ion (GO:0071294) | 2.11543600 |
| 159 | leukotriene metabolic process (GO:0006691) | 2.11299276 |
| 160 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.10036426 |
| 161 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.09718832 |
| 162 | NIK/NF-kappaB signaling (GO:0038061) | 2.09348406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.85475575 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.27562842 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.05286296 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.95642388 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.83790722 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57604579 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54690683 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54618057 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54030860 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.43485183 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43132502 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42798699 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36757696 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30078733 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26227226 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23628344 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18940401 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16385266 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.15302826 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13479262 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04889180 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01690429 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90821647 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90784454 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87752486 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86574184 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80138317 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76105107 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70777051 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69853739 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68721658 |
| 32 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64226856 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63868274 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61895950 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60527358 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59861948 |
| 37 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59438048 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57818157 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55357915 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53367031 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52001620 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50323089 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49421186 |
| 44 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47307127 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47242169 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46828689 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46826973 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46491268 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44679200 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44311868 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44049617 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43118780 |
| 53 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42794931 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42182802 |
| 55 | * P68_20966046_ChIP-Seq_HELA_Human | 1.41294945 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41280369 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39292139 |
| 58 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.37750996 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37501326 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.36792694 |
| 61 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36638198 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36463848 |
| 63 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36015554 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33451474 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33375068 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33116684 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.32834871 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32602591 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.31192396 |
| 70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30866884 |
| 71 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30641752 |
| 72 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.30347227 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29966091 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29407974 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27761809 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27096727 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26937681 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25828847 |
| 79 | MYB_26560356_Chip-Seq_TH2_Human | 1.25140279 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24101185 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23378831 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22548567 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21944346 |
| 84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19590534 |
| 85 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18045026 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18016603 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17082854 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16664401 |
| 89 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16146183 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15903444 |
| 91 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15271308 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14360669 |
| 93 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14310625 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13955062 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12939310 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12841721 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12685599 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11989715 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11655427 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10450160 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10391458 |
| 102 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10332605 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10069423 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10024857 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07936350 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07792329 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07404101 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07046421 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06509806 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06439367 |
| 111 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06345369 |
| 112 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06345369 |
| 113 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06121933 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06039977 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05466275 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05068578 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05020713 |
| 118 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04514310 |
| 119 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04052246 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03790079 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03451619 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02853557 |
| 123 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02783190 |
| 124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02428745 |
| 125 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02091546 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02066339 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02024637 |
| 128 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01630401 |
| 129 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00555324 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00253528 |
| 131 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99549386 |
| 132 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99110179 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98590964 |
| 134 | MYC_22102868_ChIP-Seq_BL_Human | 0.97453243 |
| 135 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96929144 |
| 136 | * MYB_26560356_Chip-Seq_TH1_Human | 0.96565962 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96042465 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94573556 |
| 139 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94036379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.31049368 |
| 2 | MP0003436_decreased_susceptibility_to | 3.12490022 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.04911861 |
| 4 | MP0009840_abnormal_foam_cell | 2.39148826 |
| 5 | MP0009785_altered_susceptibility_to | 2.37230680 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.32883545 |
| 7 | MP0002419_abnormal_innate_immunity | 2.21909344 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.21663533 |
| 9 | MP0006082_CNS_inflammation | 2.20633886 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.13285101 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.06966328 |
| 12 | MP0003303_peritoneal_inflammation | 2.06508874 |
| 13 | MP0005025_abnormal_response_to | 2.02604673 |
| 14 | MP0005451_abnormal_body_composition | 2.01838603 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.00829549 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.97891156 |
| 17 | MP0005083_abnormal_biliary_tract | 1.95951438 |
| 18 | MP0008260_abnormal_autophagy | 1.95357826 |
| 19 | MP0001533_abnormal_skeleton_physiology | 1.83479007 |
| 20 | MP0003724_increased_susceptibility_to | 1.80465237 |
| 21 | MP0001790_abnormal_immune_system | 1.79359311 |
| 22 | MP0005387_immune_system_phenotype | 1.79359311 |
| 23 | MP0004947_skin_inflammation | 1.78436119 |
| 24 | MP0000685_abnormal_immune_system | 1.77594212 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.76928936 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.74835180 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.70633355 |
| 28 | MP0003329_amyloid_beta_deposits | 1.59905923 |
| 29 | MP0005275_abnormal_skin_tensile | 1.59242459 |
| 30 | MP0001800_abnormal_humoral_immune | 1.57672796 |
| 31 | MP0002723_abnormal_immune_serum | 1.57260052 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.56088524 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.55515907 |
| 34 | MP0001853_heart_inflammation | 1.53527409 |
| 35 | MP0003186_abnormal_redox_activity | 1.52908334 |
| 36 | MP0003091_abnormal_cell_migration | 1.51601937 |
| 37 | MP0002405_respiratory_system_inflammati | 1.47971563 |
| 38 | MP0008469_abnormal_protein_level | 1.46030831 |
| 39 | MP0000343_altered_response_to | 1.45517814 |
| 40 | MP0001819_abnormal_immune_cell | 1.44074993 |
| 41 | MP0000751_myopathy | 1.43915316 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.43885633 |
| 43 | MP0000858_altered_metastatic_potential | 1.41060982 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.40832437 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.38078875 |
| 46 | MP0005671_abnormal_response_to | 1.36464638 |
| 47 | MP0005365_abnormal_bile_salt | 1.36197702 |
| 48 | MP0004272_abnormal_basement_membrane | 1.34981629 |
| 49 | MP0002254_reproductive_system_inflammat | 1.31191788 |
| 50 | MP0002933_joint_inflammation | 1.30849795 |
| 51 | MP0001849_ear_inflammation | 1.30787765 |
| 52 | MP0003448_altered_tumor_morphology | 1.30334091 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.29407489 |
| 54 | MP0003195_calcinosis | 1.28887783 |
| 55 | MP0001958_emphysema | 1.28802007 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.28655506 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.26610328 |
| 58 | MP0005503_abnormal_tendon_morphology | 1.24314151 |
| 59 | MP0006054_spinal_hemorrhage | 1.23782940 |
| 60 | MP0005165_increased_susceptibility_to | 1.23508764 |
| 61 | MP0005023_abnormal_wound_healing | 1.23424976 |
| 62 | MP0002060_abnormal_skin_morphology | 1.23115141 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.22762172 |
| 64 | MP0005360_urolithiasis | 1.22643752 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.22636268 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.21007418 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.20276677 |
| 68 | MP0009764_decreased_sensitivity_to | 1.19495584 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19130639 |
| 70 | MP0003828_pulmonary_edema | 1.17162464 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.17004253 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.15717075 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.15360367 |
| 74 | MP0004858_abnormal_nervous_system | 1.14177591 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.12683043 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.11810669 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.10564298 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.10421105 |
| 79 | MP0000604_amyloidosis | 1.05865449 |
| 80 | MP0002796_impaired_skin_barrier | 1.05209189 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.04547140 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.04547140 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.04372043 |
| 84 | MP0005390_skeleton_phenotype | 1.04127173 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.03212240 |
| 86 | MP0004510_myositis | 1.01696182 |
| 87 | MP0000716_abnormal_immune_system | 1.01480769 |
| 88 | MP0001873_stomach_inflammation | 0.99006936 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.98879822 |
| 90 | MP0002006_tumorigenesis | 0.98562990 |
| 91 | MP0005164_abnormal_response_to | 0.98062582 |
| 92 | MP0000490_abnormal_crypts_of | 0.97784246 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.97000195 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.96610067 |
| 95 | MP0000747_muscle_weakness | 0.95280908 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.94909900 |
| 97 | MP0000750_abnormal_muscle_regeneration | 0.94046771 |
| 98 | MP0003795_abnormal_bone_structure | 0.93851789 |
| 99 | MP0003279_aneurysm | 0.93663095 |
| 100 | MP0010307_abnormal_tumor_latency | 0.93433959 |
| 101 | MP0001851_eye_inflammation | 0.93431546 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.93112061 |
| 103 | MP0000609_abnormal_liver_physiology | 0.92998580 |
| 104 | MP0003075_altered_response_to | 0.91193659 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.90590160 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.90383981 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.89696931 |
| 108 | MP0005310_abnormal_salivary_gland | 0.88685495 |
| 109 | MP0002429_abnormal_blood_cell | 0.88581627 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.88483468 |
| 111 | MP0002398_abnormal_bone_marrow | 0.87348095 |
| 112 | MP0009763_increased_sensitivity_to | 0.87341181 |
| 113 | MP0005166_decreased_susceptibility_to | 0.87293482 |
| 114 | MP0009278_abnormal_bone_marrow | 0.87105944 |
| 115 | MP0002722_abnormal_immune_system | 0.86798988 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.86706944 |
| 117 | MP0001243_abnormal_dermal_layer | 0.84986715 |
| 118 | MP0000249_abnormal_blood_vessel | 0.84699443 |
| 119 | MP0005501_abnormal_skin_physiology | 0.84696774 |
| 120 | MP0001542_abnormal_bone_strength | 0.83807678 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.81070735 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.76533297 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.76508793 |
| 124 | MP0005330_cardiomyopathy | 0.76003601 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.75862092 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.75299049 |
| 127 | MP0008004_abnormal_stomach_pH | 0.74491236 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.74040779 |
| 129 | MP0000733_abnormal_muscle_development | 0.73313907 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.72879799 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.72679595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.11400910 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.68144177 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.53294599 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.31825519 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.15383117 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.02732176 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.92870035 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.77339854 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.64382308 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.45282168 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.45282168 |
| 12 | Axonal loss (HP:0003447) | 3.41677647 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.35842772 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27924497 |
| 15 | Interstitial pulmonary disease (HP:0006530) | 3.26161472 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.11262666 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.11262666 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.11262666 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00348223 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00348223 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00348223 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.96019539 |
| 23 | Myositis (HP:0100614) | 2.93563604 |
| 24 | Myocardial infarction (HP:0001658) | 2.89341864 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.82730507 |
| 26 | Increased connective tissue (HP:0009025) | 2.80546110 |
| 27 | Beaking of vertebral bodies (HP:0004568) | 2.65527815 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.56154510 |
| 29 | Loss of speech (HP:0002371) | 2.55085440 |
| 30 | Achilles tendon contracture (HP:0001771) | 2.54187668 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.51004549 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48860247 |
| 33 | Gingivitis (HP:0000230) | 2.45593334 |
| 34 | Cervical subluxation (HP:0003308) | 2.45586331 |
| 35 | Orchitis (HP:0100796) | 2.44998388 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.44047103 |
| 37 | Spinal rigidity (HP:0003306) | 2.42212081 |
| 38 | Atrophic scars (HP:0001075) | 2.40255167 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.40245864 |
| 40 | Recurrent skin infections (HP:0001581) | 2.39346639 |
| 41 | Urticaria (HP:0001025) | 2.39340843 |
| 42 | Petechiae (HP:0000967) | 2.36887153 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.34979102 |
| 44 | Upper limb amyotrophy (HP:0009129) | 2.34979102 |
| 45 | Spondylolisthesis (HP:0003302) | 2.34413006 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31191812 |
| 47 | Fragile skin (HP:0001030) | 2.28624836 |
| 48 | Dilatation of the ascending aorta (HP:0005111) | 2.27195163 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25880047 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.25880047 |
| 51 | Periodontitis (HP:0000704) | 2.24385402 |
| 52 | Joint stiffness (HP:0001387) | 2.24375639 |
| 53 | Abnormality of the Achilles tendon (HP:0005109) | 2.23559135 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22857430 |
| 55 | Thrombocytosis (HP:0001894) | 2.22577475 |
| 56 | Xanthomatosis (HP:0000991) | 2.22050743 |
| 57 | Short nail (HP:0001799) | 2.20483308 |
| 58 | Chronic otitis media (HP:0000389) | 2.20362869 |
| 59 | Nuclear cataract (HP:0100018) | 2.20111190 |
| 60 | Pustule (HP:0200039) | 2.19158090 |
| 61 | Abnormality of the lumbar spine (HP:0100712) | 2.18147590 |
| 62 | Ankle contracture (HP:0006466) | 2.18005480 |
| 63 | Aortic aneurysm (HP:0004942) | 2.16667243 |
| 64 | Obstructive lung disease (HP:0006536) | 2.12497064 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12497064 |
| 66 | Generalized amyotrophy (HP:0003700) | 2.11354732 |
| 67 | Prolonged neonatal jaundice (HP:0006579) | 2.10470177 |
| 68 | Thoracic kyphosis (HP:0002942) | 2.10028746 |
| 69 | Cellulitis (HP:0100658) | 2.09081219 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.08892975 |
| 71 | Joint hemorrhage (HP:0005261) | 2.08728386 |
| 72 | Thin bony cortex (HP:0002753) | 2.08124273 |
| 73 | Pathologic fracture (HP:0002756) | 2.06820050 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06131463 |
| 75 | Wormian bones (HP:0002645) | 2.05653288 |
| 76 | J-shaped sella turcica (HP:0002680) | 2.05087311 |
| 77 | Abnormality of complement system (HP:0005339) | 2.05074311 |
| 78 | Tetraparesis (HP:0002273) | 2.03907315 |
| 79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02121364 |
| 80 | Peritonitis (HP:0002586) | 2.01414358 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.00681916 |
| 82 | Blue sclerae (HP:0000592) | 1.99849819 |
| 83 | Elbow flexion contracture (HP:0002987) | 1.98395725 |
| 84 | Disinhibition (HP:0000734) | 1.97572333 |
| 85 | Neurofibrillary tangles (HP:0002185) | 1.97130323 |
| 86 | Hypertensive crisis (HP:0100735) | 1.96645223 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96000990 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 1.95486780 |
| 89 | Aortic dissection (HP:0002647) | 1.95360507 |
| 90 | Type 1 muscle fiber predominance (HP:0003803) | 1.94598006 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 1.93681234 |
| 92 | Bladder diverticulum (HP:0000015) | 1.93565459 |
| 93 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91957923 |
| 94 | Natal tooth (HP:0000695) | 1.91900243 |
| 95 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90807660 |
| 96 | Mitral regurgitation (HP:0001653) | 1.90625210 |
| 97 | Nasal polyposis (HP:0100582) | 1.90011136 |
| 98 | Premature rupture of membranes (HP:0001788) | 1.89708602 |
| 99 | Protuberant abdomen (HP:0001538) | 1.89515012 |
| 100 | Vasculitis (HP:0002633) | 1.89300399 |
| 101 | Genu recurvatum (HP:0002816) | 1.89171988 |
| 102 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87589073 |
| 103 | Upper motor neuron abnormality (HP:0002127) | 1.87486854 |
| 104 | Hyperacusis (HP:0010780) | 1.87167702 |
| 105 | Basal ganglia calcification (HP:0002135) | 1.86852637 |
| 106 | Glomerulonephritis (HP:0000099) | 1.85805303 |
| 107 | Osteomyelitis (HP:0002754) | 1.84469948 |
| 108 | Slender build (HP:0001533) | 1.83804146 |
| 109 | Increased serum ferritin (HP:0003281) | 1.83682934 |
| 110 | Nausea (HP:0002018) | 1.83617814 |
| 111 | Hand muscle atrophy (HP:0009130) | 1.83490082 |
| 112 | Poor head control (HP:0002421) | 1.82562067 |
| 113 | Ovoid vertebral bodies (HP:0003300) | 1.82297766 |
| 114 | Hematochezia (HP:0002573) | 1.81652673 |
| 115 | Steatorrhea (HP:0002570) | 1.81261121 |
| 116 | Aneurysm (HP:0002617) | 1.80494728 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.80404988 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 1.79564678 |
| 119 | Thick nail (HP:0001805) | 1.78295660 |
| 120 | Cholecystitis (HP:0001082) | 1.77025398 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 1.77025398 |
| 122 | Polycythemia (HP:0001901) | 1.76639931 |
| 123 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76144343 |
| 124 | Increased IgE level (HP:0003212) | 1.76118164 |
| 125 | Abnormality of the intrinsic pathway (HP:0010989) | 1.76041362 |
| 126 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75962768 |
| 127 | Biconcave vertebral bodies (HP:0004586) | 1.74892457 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.74314454 |
| 129 | Protrusio acetabuli (HP:0003179) | 1.74251512 |
| 130 | Gingival bleeding (HP:0000225) | 1.74071649 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.73834741 |
| 132 | IgM deficiency (HP:0002850) | 1.73580453 |
| 133 | Broad face (HP:0000283) | 1.73369461 |
| 134 | Esophageal varix (HP:0002040) | 1.73339518 |
| 135 | Skin ulcer (HP:0200042) | 1.72860071 |
| 136 | Polygenic inheritance (HP:0010982) | 1.72309368 |
| 137 | Vascular tortuosity (HP:0004948) | 1.71409754 |
| 138 | Hemorrhage of the eye (HP:0011885) | 1.70760073 |
| 139 | Rough bone trabeculation (HP:0100670) | 1.70608099 |
| 140 | Amyloidosis (HP:0011034) | 1.70544406 |
| 141 | Mucosal telangiectasiae (HP:0100579) | 1.70449225 |
| 142 | Stomatitis (HP:0010280) | 1.70326407 |
| 143 | Nephritis (HP:0000123) | 1.70042567 |
| 144 | Abnormality of the thoracic spine (HP:0100711) | 1.69969629 |
| 145 | Menorrhagia (HP:0000132) | 1.69543224 |
| 146 | Spontaneous hematomas (HP:0007420) | 1.69532462 |
| 147 | Purpura (HP:0000979) | 1.69044243 |
| 148 | Bone pain (HP:0002653) | 1.68243439 |
| 149 | Emphysema (HP:0002097) | 1.67980457 |
| 150 | Complement deficiency (HP:0004431) | 1.67744613 |
| 151 | Bulbar palsy (HP:0001283) | 1.67741710 |
| 152 | Epistaxis (HP:0000421) | 1.66641139 |
| 153 | Recurrent bronchitis (HP:0002837) | 1.66500112 |
| 154 | Recurrent viral infections (HP:0004429) | 1.65310026 |
| 155 | Nonimmune hydrops fetalis (HP:0001790) | 1.65271990 |
| 156 | Difficulty climbing stairs (HP:0003551) | 1.64649443 |
| 157 | Hydroxyprolinuria (HP:0003080) | 1.64191330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.94044728 |
| 2 | NME2 | 3.05625785 |
| 3 | TRIB3 | 2.98598245 |
| 4 | TBK1 | 2.96299090 |
| 5 | PRPF4B | 2.71441060 |
| 6 | MAP3K3 | 2.57918847 |
| 7 | PIM2 | 2.48208873 |
| 8 | MAP4K1 | 2.39490151 |
| 9 | KIT | 2.36482032 |
| 10 | MAP3K14 | 2.35708141 |
| 11 | BLK | 2.34743124 |
| 12 | SMG1 | 2.30377404 |
| 13 | TYK2 | 2.23955782 |
| 14 | IRAK3 | 2.12333527 |
| 15 | MAP2K3 | 2.10454342 |
| 16 | LIMK1 | 1.83147125 |
| 17 | PKN2 | 1.82610189 |
| 18 | LRRK2 | 1.76392617 |
| 19 | BCKDK | 1.76161793 |
| 20 | IRAK4 | 1.70368116 |
| 21 | PBK | 1.64671412 |
| 22 | MAP3K11 | 1.63883952 |
| 23 | NEK9 | 1.62498693 |
| 24 | ZAP70 | 1.62430574 |
| 25 | FLT3 | 1.55145633 |
| 26 | IKBKB | 1.54635165 |
| 27 | JAK3 | 1.52965830 |
| 28 | IKBKE | 1.51154460 |
| 29 | DDR2 | 1.50179316 |
| 30 | TGFBR2 | 1.49123989 |
| 31 | ICK | 1.46502169 |
| 32 | RPS6KA4 | 1.45903718 |
| 33 | MST1R | 1.40657042 |
| 34 | TTN | 1.37281574 |
| 35 | TAOK3 | 1.36646224 |
| 36 | MAP3K10 | 1.36353090 |
| 37 | PTK6 | 1.34715170 |
| 38 | PIK3CG | 1.32488778 |
| 39 | TRPM7 | 1.32004042 |
| 40 | CSF1R | 1.29680669 |
| 41 | MST4 | 1.26716257 |
| 42 | LMTK2 | 1.23206863 |
| 43 | TESK1 | 1.22871560 |
| 44 | EPHB1 | 1.20692573 |
| 45 | FGFR4 | 1.19951478 |
| 46 | BTK | 1.18162393 |
| 47 | STK10 | 1.15418963 |
| 48 | PDGFRA | 1.15301496 |
| 49 | CDC42BPA | 1.12806925 |
| 50 | MAPKAPK3 | 1.11667184 |
| 51 | PRKD2 | 1.09957289 |
| 52 | JAK1 | 1.08157664 |
| 53 | MAP2K2 | 1.05819265 |
| 54 | PAK4 | 1.04763787 |
| 55 | ABL2 | 1.03314751 |
| 56 | MAP3K13 | 1.01600914 |
| 57 | TEC | 1.01597987 |
| 58 | GRK7 | 0.98273544 |
| 59 | CSK | 0.95758227 |
| 60 | SYK | 0.89588683 |
| 61 | MATK | 0.88867681 |
| 62 | HCK | 0.88172137 |
| 63 | CHUK | 0.87864185 |
| 64 | PDPK1 | 0.84360640 |
| 65 | KDR | 0.82846278 |
| 66 | MAP3K6 | 0.82755475 |
| 67 | MOS | 0.81911473 |
| 68 | TGFBR1 | 0.80577587 |
| 69 | EPHA2 | 0.80535308 |
| 70 | RPS6KA2 | 0.78676011 |
| 71 | SCYL2 | 0.77454664 |
| 72 | EPHB2 | 0.75526616 |
| 73 | MAP3K1 | 0.74341096 |
| 74 | LYN | 0.72867904 |
| 75 | MAPK11 | 0.72689408 |
| 76 | BMX | 0.72269950 |
| 77 | GRK6 | 0.71340106 |
| 78 | PIM1 | 0.71224556 |
| 79 | MAPK12 | 0.71122997 |
| 80 | RIPK4 | 0.70450293 |
| 81 | EPHA3 | 0.69205124 |
| 82 | HIPK2 | 0.68668078 |
| 83 | SIK1 | 0.68541339 |
| 84 | LCK | 0.66733800 |
| 85 | JAK2 | 0.65096290 |
| 86 | ILK | 0.64781860 |
| 87 | TAOK2 | 0.63504910 |
| 88 | RPS6KB2 | 0.62968444 |
| 89 | PRKG2 | 0.62587085 |
| 90 | PRKD3 | 0.62367412 |
| 91 | ITK | 0.62260401 |
| 92 | MAP3K2 | 0.60948184 |
| 93 | TESK2 | 0.60593310 |
| 94 | PAK2 | 0.60430844 |
| 95 | EEF2K | 0.58705649 |
| 96 | PAK1 | 0.58302105 |
| 97 | TXK | 0.57684583 |
| 98 | VRK2 | 0.56296696 |
| 99 | MAPKAPK2 | 0.54730717 |
| 100 | MAPK7 | 0.54014004 |
| 101 | MAP2K1 | 0.53803113 |
| 102 | DAPK1 | 0.53026729 |
| 103 | IRAK2 | 0.52608709 |
| 104 | RPS6KA6 | 0.51539077 |
| 105 | ARAF | 0.51408444 |
| 106 | CDK6 | 0.51113036 |
| 107 | MARK2 | 0.50850212 |
| 108 | STK24 | 0.50681768 |
| 109 | FES | 0.50539640 |
| 110 | RIPK1 | 0.48950680 |
| 111 | ERBB3 | 0.48892153 |
| 112 | BRAF | 0.48661145 |
| 113 | ABL1 | 0.48269862 |
| 114 | PRKCD | 0.47147893 |
| 115 | DAPK3 | 0.46623321 |
| 116 | MAPK15 | 0.44664811 |
| 117 | PDK1 | 0.44456366 |
| 118 | EGFR | 0.43981561 |
| 119 | TAOK1 | 0.43598696 |
| 120 | EIF2AK3 | 0.43017507 |
| 121 | PRKD1 | 0.42856390 |
| 122 | MAP3K8 | 0.42101098 |
| 123 | MAPK4 | 0.41783267 |
| 124 | MTOR | 0.41751577 |
| 125 | PTK2 | 0.41582765 |
| 126 | MET | 0.41330737 |
| 127 | RPS6KC1 | 0.40968014 |
| 128 | RPS6KL1 | 0.40968014 |
| 129 | MAP3K5 | 0.40957786 |
| 130 | KSR2 | 0.40439856 |
| 131 | CAMKK2 | 0.39689374 |
| 132 | MYLK | 0.37563423 |
| 133 | FGR | 0.36301259 |
| 134 | FGFR3 | 0.35963960 |
| 135 | DYRK1B | 0.35608297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 2.89284008 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.59614300 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.58984823 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40313589 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38138517 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09959109 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.95172962 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85642012 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.79374509 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72663966 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.69878180 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.68418646 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62713129 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.61974707 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61655737 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.60907035 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.57853333 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50661932 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46749673 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45989512 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44538107 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43187879 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38372694 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31370619 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.30110052 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.28494247 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.27148960 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23422668 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19346773 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17681662 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17484204 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15100519 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14992941 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13549995 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.09764739 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07515710 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.07212848 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 1.06450696 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06340009 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.06315281 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05573808 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03632263 |
| 43 | Endocytosis_Homo sapiens_hsa04144 | 1.03204614 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01466152 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00905107 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00696432 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00516337 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.00108073 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.99676283 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99033278 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98015520 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.97997770 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97976621 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96673369 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94557167 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94250942 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93320810 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92831093 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92757761 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91887952 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.91830731 |
| 62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89424704 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88720025 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88189364 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87611124 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84014527 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82801339 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81404977 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80777378 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80340582 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78973852 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78813016 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78378084 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78107487 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.77716065 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77539089 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.77291556 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77079762 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76619193 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.76151019 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76048688 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74846047 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73793667 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73595461 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73296095 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72503959 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72423375 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72259457 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68740257 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68259276 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67860703 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67633274 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67420827 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63345032 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61615621 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.61438382 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61000361 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60832279 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60765443 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60562664 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.60125656 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59753561 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58647387 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.58214191 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57987595 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.57865406 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57199966 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56411789 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55871274 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54890575 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54491340 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54143898 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53531076 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53033992 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52858516 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52701285 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51061199 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50451793 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50148254 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50145868 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49356843 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49106496 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48130484 |
| 124 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47055843 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46796673 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46718043 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.46697103 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45428757 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44974331 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44766367 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44685512 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43157131 |
| 133 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42532507 |

